Study reveals exercise and GLP-1 RA combination preserves bone health during weight loss

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 42 sec. here
  • 19 min. at publisher
  • 📊 Quality Score:
  • News: 79%
  • Publisher: 71%

Bone News

Bone Health,Exercise,GLP-1

Combining exercise with GLP-1 RA liraglutide results in significant weight loss while preserving bone health in adults with obesity.

By Vijay Kumar MalesuReviewed by Susha Cheriyedath, M.Sc.Jun 27 2024 In a recent study published in the JAMA Network Open, a group of researchers evaluated the impact of exercise, glucagon-like peptide-1 receptor agonist liraglutide, and their combination on bone health at the hip, spine, and forearm following diet-induced weight loss in adults with obesity.

About the study The present study was conducted from August 2016 to November 2019 at Hvidovre Hospital and the University of Copenhagen. It was approved by the Regional Ethics Committee in Denmark and the Danish Medicines Agency, following Consolidated Standards of Reporting Trials guidelines. Participants aged 18-65 with a body mass index of 32-43 provided informed consent. Those with serious chronic illnesses, including diabetes, were excluded.

Study results A total of 195 participants completed the low-calorie diet and were randomized into four groups: exercise , liraglutide , combination , and placebo . BMD measurements were available for 158 to 161 participants at week 52. No participants were on osteoporosis medications, and no fragility fractures occurred. Safety outcomes were reported previously.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Combining donepezil and memantine extends lives of Alzheimer's patients, study findsAlzheimer's disease is the world's most common neurodegenerative disease, affecting more than 50 million people globally.
Source: NewsMedical - 🏆 19. / 71 Read more »

Six distinct types of depression identified in study combining brain imaging with machine learningIn the not-too-distant future, a screening assessment for depression could include a quick brain scan to identify the best treatment.
Source: medical_xpress - 🏆 101. / 51 Read more »

Study may facilitate the development of new personalized treatments for schizophrenia An International Study Publi...An international study led by the Hospital del Mar Medical Research Institute, in collaboration with researchers from the Neuropsychopharmacology Group at the University of the Basque Country (UPV/EHU) and researchers from the CIBER of Mental Health (CIBERSAM), and published in Nature Communications, may facilitate the creation of new personalized...
Source: NewsMedical - 🏆 19. / 71 Read more »

Insurance often denies GLP-1 medications for teens with type 2 diabetes, obesityHealth insurance companies often deny coverage for new medications that treat children and teens with obesity and type 2 diabetes, meaning many patients who need treatment are unable to afford it, according to a study presented at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.
Source: medical_xpress - 🏆 101. / 51 Read more »